StratCann’s latest coverage highlights steady price stabilization and rising retail cannabis sales in Canada, with Health Canada reporting a 20% year-over-year sales increase in Q2 2025 as licensed production area expands. BC’s Q3 wholesale data showed a sharp drop in wholesale sales alongside a major shift toward Direct Delivery. The week also covered a controversial petition proposing stricter cannabis rules, and several company updates, including earnings from Cannara, Nextleaf, and High Tide, as well as Ayurcann’s move into creditor protection.Jan 31, 2026 | STRATCANN Staff
Health Canada has updated information available online for adults who use cannabis for medical purposes or are considering it. This was developed in response to recommendations 44 and 45 in the final report from the 204 Legislative Review of the Cannabis Act
According to a new report from the IMF, fully eliminating non-geographic internal trade barriers could raise Canada’s real GDP by nearly 7% over time, or roughly $210 billion in today’s terms. The report focuses on large industries with the greatest economic influence, like finance, transport, and telecommunications—sectors that are highly traded across provinces and deeply embedded in input-output networks. Still, it adds to the conversation around the kinds of inter-provincial trade barriers holding back Canada’s growing cannabis sector from realizing its full potential for Canada’s economy..
